| P2093 | author name string | Sheeraz A Qureshi | |
| | Alejandro Marquez-Lara | |
| | Branko Skovrlj | |
| | Javier Z Guzman | |
| P2860 | cites work | Bone morphogenetic protein in spine surgery: current and future uses | Q28274058 |
| | Complications of iliac crest bone graft harvesting | Q28287579 |
| | Iliac crest bone graft harvest donor site morbidity. A statistical evaluation | Q28295065 |
| | Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data | Q30486207 |
| | Off-label use of bone morphogenetic proteins in the United States using administrative data | Q33653746 |
| | Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein | Q34465785 |
| | The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers | Q36875399 |
| | Cigarette smoking and musculoskeletal disorders | Q37013908 |
| | Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount | Q37030161 |
| | Biology of BMP signalling and cancer. | Q37416802 |
| | Bone morphogenetic protein and bone metastasis, implication and therapeutic potential | Q37825184 |
| | Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review | Q37894438 |
| | Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis | Q38115448 |
| | High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo | Q42094508 |
| | Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research | Q42604263 |
| | Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages | Q42635706 |
| | Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest | Q43706574 |
| | Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein | Q46971269 |
| | Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis | Q47676550 |
| | A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. | Q47825534 |
| | Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information? | Q48222689 |
| | Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies | Q48360114 |
| | Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. | Q51446820 |
| | Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. | Q53666263 |
| | Donor site pain from the ilium. A complication of lumbar spine fusion. | Q54347528 |
| | The use of bone morphogenetic protein in the treatment of non-union in a canine model | Q70178924 |
| | The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects | Q72501474 |
| | Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein | Q72852440 |
| | Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device | Q73224423 |
| | The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report | Q73511686 |
| | Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety | Q77924929 |
| | Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages | Q78412809 |
| | Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft | Q79261703 |
| | Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures | Q84147862 |
| | Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial | Q84154758 |
| | Senators question Medtronic about unreported side effects of spinal protein | Q84509349 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bias | Q742736 |
| | morphogenesis | Q815547 |
| P304 | page(s) | 182-8 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Current reviews in musculoskeletal medicine | Q26841992 |
| P1476 | title | A review of the current published spinal literature regarding bone morphogenetic protein-2: an insight into potential bias | |
| P478 | volume | 7 | |